cupure logo
trumptariffsheresclairestrumpsbanktaxinterestcutmdash

GLP-1 weight-loss pills are coming. So are doubts about their potency.

Eli Lilly will seek regulatory approval for its next-generation weight-loss pill by year-end, based on data that suggests it may not be as potent as injectable GLP-1 drugs on the market.

Comments

Business News